Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373880 · ClinicalTrials.gov registry record · Phase 2
Effects of Aripiprazole on Cocaine Craving and Self-Administration
A Phase 2 study of Cocaine Abuse, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT00373880 is a Phase 2 study of Cocaine Abuse that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 26 participants, below the 916-participant average among 9 other Cocaine Abuse trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00373880, a Phase 2 study of Cocaine Abuse, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate whether aripiprazole will decrease cocaine self-administration, subjective effects and cravings compared to placebo.
Conditions Studied
Interventions
- DRUG Aripiprazole + Cocaine
- DRUG Placebo + Cocaine
Study Locations (1)
New York
- Irving Center for Clinical Research - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373880
The ClinicalTrials.gov registry entry for NCT00373880 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 916-participant average among 9 other Cocaine Abuse trials with a reported enrollment target (97% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Abuse appearing as the primary indexed condition, and to 2 interventions - of which Aripiprazole + Cocaine is the first listed.
NCT00373880 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00373880 about?
NCT00373880 is a clinical study titled "Effects of Aripiprazole on Cocaine Craving and Self-Administration". The purpose of this study is to investigate whether aripiprazole will decrease cocaine self-administration, subjective effects and cravings compared to placebo.
What is the current status of trial NCT00373880?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2005-04. Estimated completion is 2008-09.
What conditions does trial NCT00373880 study?
This clinical trial studies the following conditions: Cocaine Abuse.
What interventions are being tested in trial NCT00373880?
The interventions under investigation include: Aripiprazole + Cocaine (DRUG), Placebo + Cocaine (DRUG).
Who is sponsoring clinical trial NCT00373880?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00373880 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Therapeutic Substance Abuse Treatment in Pregnancy - 1
COMPLETED · Phase 2
-
Substance Abuse Pre-Treatment Screening Study
RECRUITING
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
-
Exercise as a Behavioral Treatment for Cocaine Dependence
COMPLETED · NA
-
Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
COMPLETED · Phase 1
-
CBT With Disulfiram and Contingency Management
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.